本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

West Pharmaceutical Services Inc

263.64
+2.280.87%
成交量:12.55万
成交额:3,307.93万
市值:189.67亿
市盈率:39.05
高:266.13
开:261.40
低:260.60
收:261.36
52周最高:348.90
52周最低:187.43
股本:7,194.34万
流通股本:7,141.24万
量比:0.74
换手率:0.18%
股息:0.84
股息率:0.32%
每股收益(TTM):6.75
每股收益(LYR):6.75
净资产收益率:16.94%
总资产收益率:10.22%
市净率:6.22
市盈率(LYR):39.06

数据加载中...

2024/10/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/10/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/10/08

重要事件披露

Form 8-K - Current report
2024/08/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/25

重要事件披露

Form 8-K - Current report
2024/07/08

重要事件披露

Form 8-K - Current report
2024/06/26

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/06/26

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/26

重要事件披露

Form 8-K - Current report
2024/04/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

重要事件披露

Form 8-K - Current report
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/01

重要事件披露

Form 8-K - Current report
2023/10/27

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]